ARDAT PROJECT

January 27, 2025

A new year, new classes, and a deep dive into advanced therapies, including discussions on the ARDAT project, as part of the University of Sheffield’s Advanced Cell and Gene Therapies MSc course at the Sheffield Institute of Translational Neuroscience (SITraN).

Over the course of the year, students will dive into the cutting-edge world of cell and gene therapies, with guidance from Professors Mimoun Azzouz and Janine Kirby. Topics include rare inherited diseases, personalized treatments, molecular biology techniques, and translating therapies from the lab to the market.

The ARDAT project, a collaboration of 32 international partners from academia, industry, and small/medium enterprises, is focused on advancing our knowledge in viral gene/cell therapy to accelerate the development of new treatments for rare diseases.

It was an exciting opportunity last week for Asphalion’s expert Chris Mann to share insights with a great group of students, and none of them will ever look at pineapple pizza the same way again!

If you want to know more have a look at the website for details of the next course:

https://www.sheffield.ac.uk/postgraduate/taught/courses/2025/advanced-cell-and-gene-therapies-msc

About ARDAT: https://ardat.org/

Need help in your ATMPs endeavours? We are experts! Contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

HORIZON EUROPE | NABIHEAL progress meeting

Two years into the NABIHEAL project, Asphalion experts Marta Rayo Lunar and Sergio Veiga attended the consortium meeting in Zagreb, hosted by IMI, to review

HORIZON EUROPE PROJECT | KeratOPrinter Kick-Off Meeting

Corneal blindness affects over 11.7 million people worldwide, yet only 1 in 70 patients receive a corneal transplant due to a severe donor shortage. The KeratOPrinter project aims to address this gap by developing a groundbreaking 4D bioprinting suite capable of producing fully functional, biocompatible human corneas. Combining expertise from world-class partners, the project focuses on scalable cell sources, advanced bioinks, high-precision bioprinting, clinical handling solutions, regulatory compliance, and a strong collaborative network. By 2035, KeratOPrinter seeks to revolutionize corneal transplantation and restore vision for millions.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting